Sarepta Therapeutics, Inc. — Director's Dealing 2010

Jun 9, 2010

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AVI BIOPHARMA INC (AVII)
CIK: 0000873303
Period of Report: 2010-06-08

Reporting Person: Christopher Nishan Garabedian (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2010-06-08	Non-Qualified Stock Option (right to buy)	$1.3	A	60000	Acquired	2020-06-08	Common Stock (60000)	Direct

Footnotes

F1: These options vest ratably over four years of continued service to the Board of Directors,with 1/4 of the total amount of shares vesting each year on the earlier of (i) the anniversary date of the grant or (ii) the date of the Annual Meeting in the year following the date of grant.